Friday, July 12, 2013

Washington Post's Pessimistic View of "Emipre II"

Here is the Washington Post's pessimistic view of Myriad chances in overcoming AMP v Myriad's holding of invalidity of gene patents.  I am not so pessimistic.  I think Myriad's claims can be overcome or designed around.
http://www.washingtonpost.com/blogs/wonkblog/wp/2013/07/12/you-cant-patent-human-genes-so-why-are-genetic-testing-companies-getting-sued/

No comments:

Post a Comment